AVORO CAPITAL ADVISORS LLC – BioMarin Pharmaceutical Inc. Transaction History
AVORO CAPITAL ADVISORS LLC portfolio value:
$301.40M
portfolio value
AVORO CAPITAL ADVISORS LLC quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +8.27% | 271.55K shares | 29.25M | $84.77 | 3.55M |
| Q2 2022 | share | Increase | +8.20% | 249K shares | 38.14M | $82.87 | 3.28M |
| Q1 2022 | share | Increase | +8.39% | 235K shares | -13.38M | $77.1 | 3.03M |
| Q4 2021 | share | Increase | +49.33% | 925K shares | 102.46M | $89.08 | 2.8M |
| Q3 2021 | share | Increase | +13.64% | 225K shares | 7.24M | $77.29 | 1.87M |
| Q2 2021 | share | 0.00% | 0 shares | 13.08M | $83.44 | 1.65M | |
| Q1 2021 | share | 0.00% | 0 shares | -20.09M | $75.51 | 1.65M | |
| Q4 2020 | share | Decrease | -5.71% | -100K shares | 11.54M | $87.69 | 1.65M |
| Q3 2020 | share | Decrease | -5.41% | -100K shares | -95.03M | $76.08 | 1.75M |
| Q2 2020 | share | Decrease | -4.15% | -80K shares | 65.09M | $123.34 | 1.85M |
| Q1 2020 | share | Decrease | -3.50% | -70K shares | -6.01M | $84.5 | 1.93M |
| Q4 2019 | share | Decrease | -17.94% | -437.1K shares | 4.83M | $84.55 | 2M |
| Q3 2019 | share | Increase | +15.23% | 322.1K shares | -16.88M | $67.4 | 2.43M |
| Q2 2019 | share | Increase | +88.84% | 995K shares | 81.66M | $85.65 | 2.11M |
| Q1 2019 | share | Increase | 0.00% | 1.12M shares | 99.49M | $88.83 | 1.12M |
| Q4 2018 | share | Decrease | -0.59% | -8.10K shares | -16.86M | $85.15 | 1.36M |
| Q3 2018 | share | Decrease | -15.69% | -254.66K shares | -20.2M | $96.97 | 1.36M |
| Q2 2018 | share | Decrease | -5.16% | -88.22K shares | 14.15M | $94.2 | 1.62M |
| Q2 2018 | call | Decrease | -100.00% | -162.5K shares | -214K | $94.2 | 0 |
| Q1 2018 | share | Increase | +43.84% | 521.47K shares | 32.64M | $81.07 | 1.71M |
| Q1 2018 | call | Decrease | -45.83% | -137.5K shares | 79K | $81.07 | 162.5K |
| Q4 2017 | share | Increase | +98.93% | 591.55K shares | 50.41M | $89.17 | 1.18M |
| Q4 2017 | call | Increase | 0.00% | 300K shares | 135K | $89.17 | 300K |
| Q3 2017 | share | Increase | +19.41% | 97.18K shares | 10.17M | $93.07 | 597.97K |
| Q2 2017 | share | Decrease | -15.12% | -89.21K shares | -6.30M | $90.82 | 500.78K |
| Q1 2017 | share | Increase | +47.50% | 190K shares | 18.65M | $87.78 | 590K |
| Q4 2016 | share | Decrease | -4.70% | -19.71K shares | -5.69M | $82.84 | 400K |
| Q3 2016 | share | Decrease | -3.06% | -13.26K shares | 5.14M | $92.52 | 419.71K |
| Q2 2016 | share | Increase | +56.15% | 155.7K shares | 10.81M | $77.8 | 432.97K |
| Q1 2016 | share | Increase | 0.00% | 277.27K shares | 22.86M | $82.48 | 277.27K |